Strategies to improve the immunogenicity of anticancer vaccines based on dendritic cell/malignant cell fusions

The rationale for fusing dendritic cells (DCs) with whole tumor cells to generate anticancer vaccines resides in the fact that the former operate as potent antigen-presenting cells, whereas the latter express a constellation of tumor-associated antigens (TAAs). Although the administration of DC/mali...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Koido, Shigeo, Homma, Sadamu, Okamoto, Masato, Namiki, Yoshihisa, Takakura, Kazuki, Uchiyama, Kan, Kajihara, Mikio, Arihiro, Seiji, Imazu, Hiroo, Arakawa, Hiroshi, Kan, Shin, Komita, Hideo, Kamata, Yuko, Ito, Masaki, Ohkusa, Toshifumi, Gong, Jianlin, Tajiri, Hisao
Format: Artigo
Idioma:Inglês
Publicat: Landes Bioscience 2013
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3820816/
https://ncbi.nlm.nih.gov/pubmed/24228229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.25994
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars